http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003021844-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2002-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70407e4cd2a2ad0db18c048ec07ad771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4efe7eb0979ef12eedc3d169119f6e67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3dde2e115642eb7d7411886d1c4b73
publicationDate 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003021844-A1
titleOfInvention Immediate-release oral pellet comprising polyglycolysed glycerides, and manufacturing process
abstract The invention concerns a pellet for immediate release of an active substance to be ingested, said pellet comprising at least one active substance, a binding agent and a diluting agent, characterised in that said binding agent: comprises a mixture of glycerides subjected to polyglycolysis whereof the fatty acids comprise at least 8 carbon atoms; has a melting point not less than 37° C.; has a hydrophilic/lipophilic balance not less than 10, said binding agent being capable of enhancing the active substance bioavailability.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007148153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10704037-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005220866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016071434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008019959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005250817-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10072256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014178469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007148152-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802087-B2
priorityDate 1998-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129381420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409497

Total number of triples: 46.